PharmiWeb12d
CHMP recommends subcutaneous RYBREVANT® (amivantamab) for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer
Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...
Pharmabiz11d
EMA committee recommends extension of marketing authorisation for Janssen-Cilag’s subcutaneous Rybrevant to treat advanced EGFR-mutated NSCLC
EMA committee recommends extension of marketing authorisation for Janssen-Cilag’s subcutaneous Rybrevant to treat advanced EGFR-mutated NSCLC: Beerse, Belgium Tuesday, February ...
Lahontan Announces Closing of Private Placement and Sale of Common Shares by Victoria Gold Corp.
Lahontan Gold Corp. (TSXV: LG) (OTCQB: LGCXF) (the "Company" or "Lahontan") is pleased to announce that, further to its press ...
usace.army.mil2d
USAISR, MIT team up on AI tool for nerve block anesthetics
USAISR is working with MIT Lincoln Lab to develop a new device for providing regional pain control in trauma patients at or ...
protothema.gr2d
Investigation at Volos hospital after parents’ complaint about burns to infant from serum
An Administrative Inquiry was ordered at Volos Hospital, following the complaint by parents that a four-month-old infant ...
PMLiVE12d
J&J’s subcutaneous Rybrevant receives positive CHMP opinion for advanced lung cancer
The Committee for Medicinal Products for Human Use (CHMP) has recommended that the subcutaneous (SC) formulation be approved ...
TCTMD3d
Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT
These early data are reassuring, but there are many questions yet to be explored in the upcoming pivotal trial, Nancy ...
Stockhead on MSN16d
ASX Quarterly Health Wrap: Bioxyne revenue up 77%, Radiopharm lists on Nasdaq
Bioxyne lifts revenue 77% QoQ; Radiopharm listed on the Nasdaq in the December quarter; Tryptomine hits key milestones; Quarterly season is nearing its end, triggering a rush from ...
2025 NFL Draft Big Board: Who are the top 100 prospects in this year’s class?
There will be some fluctuation before draft weekend, but we have a clearer frame of reference as the final rankings come into ...
Le Lézard8d
Converge Technology Solutions to be Acquired by H.I.G. Capital
H.I.G. Capital to acquire Converge in an all-cash transaction, providing immediate liquidity to shareholders while establishing a strategic partner for Converge to execute its long-term growth ...